hologic ltd.
hologic ltd. Company Information
Company Number
02722343
Next Accounts
Jun 2025
Shareholders
gen-probe inc.
Group Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
+2Registered Address
heron house oaks business park, crewe road, wythenshawe, manchester, M23 9HZ
Website
http://hologic.comhologic ltd. Estimated Valuation
Pomanda estimates the enterprise value of HOLOGIC LTD. at £224.9m based on a Turnover of £156.9m and 1.43x industry multiple (adjusted for size and gross margin).
hologic ltd. Estimated Valuation
Pomanda estimates the enterprise value of HOLOGIC LTD. at £65.8m based on an EBITDA of £9.2m and a 7.15x industry multiple (adjusted for size and gross margin).
hologic ltd. Estimated Valuation
Pomanda estimates the enterprise value of HOLOGIC LTD. at £141.4m based on Net Assets of £70.8m and 2x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Hologic Ltd. Overview
Hologic Ltd. is a live company located in wythenshawe, M23 9HZ with a Companies House number of 02722343. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in June 1992, it's largest shareholder is gen-probe inc. with a 100% stake. Hologic Ltd. is a mature, mega sized company, Pomanda has estimated its turnover at £156.9m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Hologic Ltd. Health Check
Pomanda's financial health check has awarded Hologic Ltd. a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
4 Weak
Size
annual sales of £156.9m, make it larger than the average company (£13m)
£156.9m - Hologic Ltd.
£13m - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (5.4%)
-12% - Hologic Ltd.
5.4% - Industry AVG
Production
with a gross margin of 11.3%, this company has a higher cost of product (43.6%)
11.3% - Hologic Ltd.
43.6% - Industry AVG
Profitability
an operating margin of 3.7% make it less profitable than the average company (5.6%)
3.7% - Hologic Ltd.
5.6% - Industry AVG
Employees
with 287 employees, this is above the industry average (58)
287 - Hologic Ltd.
58 - Industry AVG
Pay Structure
on an average salary of £63.7k, the company has an equivalent pay structure (£58.4k)
£63.7k - Hologic Ltd.
£58.4k - Industry AVG
Efficiency
resulting in sales per employee of £546.5k, this is more efficient (£214.1k)
£546.5k - Hologic Ltd.
£214.1k - Industry AVG
Debtor Days
it gets paid by customers after 41 days, this is earlier than average (56 days)
41 days - Hologic Ltd.
56 days - Industry AVG
Creditor Days
its suppliers are paid after 10 days, this is quicker than average (38 days)
10 days - Hologic Ltd.
38 days - Industry AVG
Stock Days
it holds stock equivalent to 86 days, this is in line with average (84 days)
86 days - Hologic Ltd.
84 days - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Hologic Ltd.
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 29.3%, this is a lower level of debt than the average (47.4%)
29.3% - Hologic Ltd.
47.4% - Industry AVG
HOLOGIC LTD. financials
Hologic Ltd.'s latest turnover from September 2023 is £156.9 million and the company has net assets of £70.8 million. According to their latest financial statements, Hologic Ltd. has 287 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 156,859,000 | 229,622,000 | 450,649,000 | 229,699,000 | 93,195,000 | 72,041,000 | 68,369,000 | 62,793,000 | 50,780,000 | 17,279,000 | 17,172,000 | 7,939,000 | 6,497,000 | 8,814,000 | 10,234,000 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 139,203,000 | 210,167,000 | 427,385,000 | 208,768,000 | 77,979,000 | 58,931,000 | 55,849,000 | 48,314,000 | 31,587,000 | 12,042,000 | 13,127,000 | 5,480,000 | 3,904,000 | 5,125,000 | 5,147,000 |
| Gross Profit | 17,656,000 | 19,455,000 | 23,264,000 | 20,931,000 | 15,216,000 | 13,110,000 | 12,520,000 | 14,479,000 | 19,193,000 | 5,237,000 | 4,045,000 | 2,459,000 | 2,593,000 | 3,689,000 | 5,087,000 |
| Admin Expenses | 11,899,000 | 10,040,000 | 9,930,000 | 10,942,000 | 11,548,000 | 11,810,000 | 10,236,000 | 12,439,000 | 19,395,000 | 8,398,000 | 7,457,000 | 5,433,000 | 3,697,000 | 3,017,000 | 7,244,000 |
| Operating Profit | 5,757,000 | 9,415,000 | 13,334,000 | 9,989,000 | 3,668,000 | 1,300,000 | 2,284,000 | 2,040,000 | -202,000 | -3,161,000 | -3,412,000 | -2,974,000 | -1,104,000 | 672,000 | -2,157,000 |
| Interest Payable | 69,000 | 417,000 | 1,294,000 | 170,000 | 24,000 | 4,000 | 67,000 | 106,000 | 80,000 | 15,000 | 225,000 | 104,000 | 164,000 | ||
| Interest Receivable | 83,000 | 5,000 | 1,000 | 18,000 | 35,000 | 70,000 | 390,000 | 105,000 | |||||||
| Pre-Tax Profit | 5,771,000 | 8,998,000 | 12,040,000 | 9,443,000 | 3,649,000 | 1,296,000 | 2,285,000 | 2,093,000 | 4,485,000 | -2,811,000 | -2,733,000 | -2,811,000 | -2,100,000 | 328,000 | 920,000 |
| Tax | -334,000 | -3,543,000 | -416,000 | -632,000 | -657,000 | -371,000 | -482,000 | 4,289,000 | -381,000 | ||||||
| Profit After Tax | 5,437,000 | 5,455,000 | 11,624,000 | 8,811,000 | 2,992,000 | 925,000 | 1,803,000 | 6,382,000 | 4,485,000 | -2,811,000 | -2,733,000 | -2,811,000 | -2,481,000 | 328,000 | 920,000 |
| Dividends Paid | |||||||||||||||
| Retained Profit | 5,437,000 | 5,455,000 | 11,624,000 | 8,811,000 | 2,992,000 | 925,000 | 1,803,000 | 6,382,000 | 4,485,000 | -2,811,000 | -2,733,000 | -2,811,000 | -2,481,000 | 328,000 | 920,000 |
| Employee Costs | 18,290,000 | 18,995,000 | 17,306,000 | 13,395,000 | 13,021,000 | 12,573,000 | 12,496,000 | 10,712,000 | 16,625,000 | 6,348,000 | 5,143,000 | 4,811,000 | 4,188,000 | 3,826,000 | 5,094,000 |
| Number Of Employees | 287 | 270 | 244 | 213 | 232 | 243 | 249 | 214 | 221 | 145 | 132 | 142 | 112 | 115 | 148 |
| EBITDA* | 9,207,000 | 12,702,000 | 16,585,000 | 13,346,000 | 6,798,000 | 4,569,000 | 5,401,000 | 5,306,000 | 3,600,000 | -1,428,000 | -1,770,000 | -1,970,000 | -81,000 | 1,442,000 | -1,455,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 26,337,000 | 26,889,000 | 26,965,000 | 22,452,000 | 18,504,000 | 17,907,000 | 17,929,000 | 17,061,000 | 17,302,000 | 14,139,000 | 14,017,000 | 13,546,000 | 10,690,000 | 6,319,000 | 5,259,000 |
| Intangible Assets | 5,000 | 21,000 | 40,000 | 76,000 | 109,000 | 169,000 | 215,000 | ||||||||
| Investments & Other | 9,800,000 | 207,000 | 607,000 | ||||||||||||
| Debtors (Due After 1 year) | 1,979,000 | 634,000 | 1,870,000 | 2,217,000 | 2,730,000 | 3,436,000 | 3,807,000 | 4,289,000 | 400,000 | ||||||
| Total Fixed Assets | 28,316,000 | 27,523,000 | 28,835,000 | 24,669,000 | 21,234,000 | 21,343,000 | 21,736,000 | 21,350,000 | 17,307,000 | 23,960,000 | 14,057,000 | 13,622,000 | 10,799,000 | 7,095,000 | 6,081,000 |
| Stock & work in progress | 33,133,000 | 31,543,000 | 39,874,000 | 27,240,000 | 10,025,000 | 8,604,000 | 7,314,000 | 6,429,000 | 3,756,000 | 2,019,000 | 3,852,000 | 3,719,000 | 506,000 | 764,000 | 1,552,000 |
| Trade Debtors | 17,850,000 | 17,774,000 | 25,294,000 | 36,408,000 | 14,988,000 | 11,654,000 | 8,514,000 | 8,103,000 | 8,458,000 | 2,520,000 | 2,471,000 | 1,943,000 | 1,173,000 | 1,281,000 | 2,308,000 |
| Group Debtors | 19,602,000 | 27,833,000 | 11,100,000 | 6,855,000 | 7,119,000 | 9,712,000 | 13,759,000 | 9,455,000 | 1,202,000 | 1,492,000 | 18,000 | 2,252,000 | 2,405,000 | 1,878,000 | 2,264,000 |
| Misc Debtors | 1,161,000 | 5,993,000 | 2,803,000 | 856,000 | 1,054,000 | 1,168,000 | 1,074,000 | 1,119,000 | 1,119,000 | 1,190,000 | 917,000 | 2,657,000 | 3,204,000 | 1,239,000 | 594,000 |
| Cash | 524,000 | 2,000 | 1,323,000 | 1,168,000 | 6,356,000 | 2,058,000 | 2,004,000 | 2,031,000 | 3,131,000 | 622,000 | 8,493,000 | ||||
| misc current assets | 7,544,000 | ||||||||||||||
| total current assets | 71,746,000 | 83,143,000 | 79,595,000 | 71,359,000 | 33,188,000 | 31,138,000 | 31,984,000 | 26,274,000 | 20,891,000 | 9,279,000 | 9,262,000 | 12,602,000 | 10,419,000 | 13,328,000 | 15,211,000 |
| total assets | 100,062,000 | 110,666,000 | 108,430,000 | 96,028,000 | 54,422,000 | 52,481,000 | 53,720,000 | 47,624,000 | 38,198,000 | 33,239,000 | 23,319,000 | 26,224,000 | 21,218,000 | 20,423,000 | 21,292,000 |
| Bank overdraft | 13,000 | 97,000 | 64,000 | ||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 4,064,000 | 3,486,000 | 2,766,000 | 3,972,000 | 3,693,000 | 1,845,000 | 935,000 | 1,575,000 | 1,875,000 | 575,000 | 347,000 | 540,000 | 421,000 | 633,000 | 1,234,000 |
| Group/Directors Accounts | 6,538,000 | 22,607,000 | 23,715,000 | 25,551,000 | 2,785,000 | 6,051,000 | 9,847,000 | 6,034,000 | 130,000 | 44,000 | 1,857,000 | 7,018,000 | 1,187,000 | 948,000 | |
| other short term finances | |||||||||||||||
| hp & lease commitments | 38,000 | 81,000 | 76,000 | ||||||||||||
| other current liabilities | 18,183,000 | 18,649,000 | 21,577,000 | 17,757,000 | 8,007,000 | 7,640,000 | 6,730,000 | 5,510,000 | 7,880,000 | 2,948,000 | 1,873,000 | 2,456,000 | 2,383,000 | 3,098,000 | 4,587,000 |
| total current liabilities | 28,798,000 | 44,839,000 | 48,058,000 | 47,280,000 | 14,485,000 | 15,536,000 | 17,512,000 | 13,119,000 | 9,885,000 | 3,567,000 | 4,077,000 | 10,014,000 | 4,029,000 | 4,760,000 | 5,961,000 |
| loans | 7,173,000 | 7,214,000 | 1,597,000 | 464,000 | |||||||||||
| hp & lease commitments | 33,000 | 114,000 | |||||||||||||
| Accruals and Deferred Income | 98,000 | ||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 688,000 | 788,000 | 978,000 | 549,000 | 549,000 | 500,000 | 615,000 | 720,000 | |
| total long term liabilities | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 688,000 | 788,000 | 978,000 | 7,722,000 | 7,763,000 | 2,097,000 | 615,000 | 753,000 | 676,000 |
| total liabilities | 29,298,000 | 45,339,000 | 48,558,000 | 47,780,000 | 14,985,000 | 16,036,000 | 18,200,000 | 13,907,000 | 10,863,000 | 11,289,000 | 11,840,000 | 12,111,000 | 4,644,000 | 5,513,000 | 6,637,000 |
| net assets | 70,764,000 | 65,327,000 | 59,872,000 | 48,248,000 | 39,437,000 | 36,445,000 | 35,520,000 | 33,717,000 | 27,335,000 | 21,950,000 | 11,479,000 | 14,113,000 | 16,574,000 | 14,910,000 | 14,655,000 |
| total shareholders funds | 70,764,000 | 65,327,000 | 59,872,000 | 48,248,000 | 39,437,000 | 36,445,000 | 35,520,000 | 33,717,000 | 27,335,000 | 21,950,000 | 11,479,000 | 14,113,000 | 16,574,000 | 14,910,000 | 14,655,000 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 5,757,000 | 9,415,000 | 13,334,000 | 9,989,000 | 3,668,000 | 1,300,000 | 2,284,000 | 2,040,000 | -202,000 | -3,161,000 | -3,412,000 | -2,974,000 | -1,104,000 | 672,000 | -2,157,000 |
| Depreciation | 3,450,000 | 3,287,000 | 3,251,000 | 3,357,000 | 3,130,000 | 3,269,000 | 3,117,000 | 3,261,000 | 3,786,000 | 1,733,000 | 1,606,000 | 971,000 | 963,000 | 724,000 | 680,000 |
| Amortisation | 5,000 | 16,000 | 36,000 | 33,000 | 60,000 | 46,000 | 22,000 | ||||||||
| Tax | -334,000 | -3,543,000 | -416,000 | -632,000 | -657,000 | -371,000 | -482,000 | 4,289,000 | -381,000 | ||||||
| Stock | 1,590,000 | -8,331,000 | 12,634,000 | 17,215,000 | 1,421,000 | 1,290,000 | 885,000 | 2,673,000 | 1,737,000 | -1,833,000 | 133,000 | 3,213,000 | -258,000 | -788,000 | 1,552,000 |
| Debtors | -11,642,000 | 11,167,000 | -5,269,000 | 20,445,000 | -79,000 | -1,184,000 | 4,188,000 | 12,187,000 | 5,577,000 | 1,796,000 | -3,446,000 | 70,000 | 1,984,000 | -368,000 | 5,166,000 |
| Creditors | 578,000 | 720,000 | -1,206,000 | 279,000 | 1,848,000 | 910,000 | -640,000 | -300,000 | 1,300,000 | 228,000 | -193,000 | 119,000 | -212,000 | -601,000 | 1,234,000 |
| Accruals and Deferred Income | -466,000 | -2,928,000 | 3,820,000 | 9,750,000 | 367,000 | 910,000 | 1,220,000 | -2,370,000 | 4,932,000 | 1,075,000 | -583,000 | 73,000 | -715,000 | -1,587,000 | 4,685,000 |
| Deferred Taxes & Provisions | -188,000 | -100,000 | -190,000 | 429,000 | 49,000 | -115,000 | -105,000 | 720,000 | |||||||
| Cash flow from operations | 19,037,000 | 4,115,000 | 11,418,000 | -14,917,000 | 7,014,000 | 5,724,000 | 326,000 | -8,125,000 | 2,947,000 | 816,000 | -5,176,000 | -3,220,000 | 1,130,000 | -2,254,000 | |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -9,800,000 | 9,800,000 | -207,000 | -400,000 | 607,000 | ||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -16,069,000 | -1,108,000 | -1,836,000 | 22,766,000 | -3,266,000 | -3,796,000 | 3,813,000 | 5,904,000 | 86,000 | -1,813,000 | -5,161,000 | 5,831,000 | 239,000 | 948,000 | |
| Other Short Term Loans | |||||||||||||||
| Long term loans | -7,173,000 | -41,000 | 5,617,000 | 1,597,000 | -464,000 | 464,000 | |||||||||
| Hire Purchase and Lease Commitments | -38,000 | -76,000 | -76,000 | 190,000 | |||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 14,000 | -417,000 | -1,294,000 | -170,000 | -19,000 | -4,000 | 1,000 | 18,000 | -67,000 | -106,000 | -80,000 | 20,000 | -155,000 | 286,000 | -59,000 |
| cash flow from financing | -16,055,000 | -1,525,000 | -3,130,000 | 22,596,000 | -3,285,000 | -3,800,000 | 3,814,000 | 5,922,000 | -6,254,000 | 11,322,000 | 475,000 | 7,760,000 | 4,153,000 | 621,000 | 14,330,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -524,000 | 524,000 | -2,000 | 2,000 | -1,323,000 | 155,000 | -5,188,000 | 4,298,000 | 54,000 | -27,000 | -1,100,000 | 2,509,000 | -7,871,000 | 8,493,000 | |
| overdraft | -84,000 | 97,000 | -64,000 | 64,000 | |||||||||||
| change in cash | 84,000 | -621,000 | 524,000 | -2,000 | 2,000 | -1,323,000 | 155,000 | -5,188,000 | 4,298,000 | 54,000 | -27,000 | -1,100,000 | 2,509,000 | -7,807,000 | 8,429,000 |
hologic ltd. Credit Report and Business Information
Hologic Ltd. Competitor Analysis
Perform a competitor analysis for hologic ltd. by selecting its closest rivals, whether from the MANUFACTURING sector, other mega companies, companies in M23 area or any other competitors across 12 key performance metrics.
hologic ltd. Ownership
HOLOGIC LTD. group structure
Hologic Ltd. has no subsidiary companies.
Ultimate parent company
HOLOGIC INC
#0055908
GEN-PROBE INC
#0049149
2 parents
HOLOGIC LTD.
02722343
hologic ltd. directors
Hologic Ltd. currently has 3 directors. The longest serving directors include Mr Hans Berrendorf (Feb 2010) and Michelangelo Stefani (Oct 2016).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Hans Berrendorf | Germany | 69 years | Feb 2010 | - | Director |
| Michelangelo Stefani | Belgium | 59 years | Oct 2016 | - | Director |
| Mr Joseph Kisby | England | 42 years | Mar 2022 | - | Director |
P&L
September 2023turnover
156.9m
-32%
operating profit
5.8m
-39%
gross margin
11.3%
+32.85%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
70.8m
+0.08%
total assets
100.1m
-0.1%
cash
0
0%
net assets
Total assets minus all liabilities
hologic ltd. company details
company number
02722343
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
72190 - Other research and experimental development on natural sciences and engineering
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
June 1992
age
33
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
September 2023
previous names
gen-probe life sciences ltd. (March 2014)
tepnel life sciences plc (April 2009)
See moreaccountant
-
auditor
ERNST & YOUNG LLP
address
heron house oaks business park, crewe road, wythenshawe, manchester, M23 9HZ
Bank
THE ROYAL BANK OF SCOTLAND PLC, THE ROYAL BANK OF SCOTLAND PLC
Legal Advisor
-
hologic ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to hologic ltd.. Currently there are 0 open charges and 8 have been satisfied in the past.
hologic ltd. Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HOLOGIC LTD.. This can take several minutes, an email will notify you when this has completed.
hologic ltd. Companies House Filings - See Documents
| date | description | view/download |
|---|
